Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 6 of 102 for:    stem cell arthritis AND Mesenchymal

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Rheumatoid Arthritis (HB-adMSCs)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03691909
Recruitment Status : Active, not recruiting
First Posted : October 2, 2018
Last Update Posted : August 26, 2019
Sponsor:
Information provided by (Responsible Party):
Hope Biosciences

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : February 1, 2020
Estimated Study Completion Date : March 1, 2020